Amanote Research
Register
Sign In
The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
Frontiers in Immunology
- Switzerland
doi 10.3389/fimmu.2019.02354
Full Text
Open PDF
Abstract
Available in
full text
Categories
Allergy
Immunology
Date
October 17, 2019
Authors
Haoyu Sun
Cheng Sun
Publisher
Frontiers Media SA
Related search
Aptamers as a Promising Therapeutic Tool for Cancer Immunotherapy
Defective Cell Cycle Checkpoints as Targets for Anti-Cancer Therapies
Frontiers in Pharmacology
Pharmacology
The Blockade of Immune Checkpoints in Cancer Immunotherapy
Nature Reviews Cancer
Cancer Research
Oncology
Cell Surface Proteoglycans as Potential Targets for Immunotherapy in Women's Cancer
Journal of Gynecology and Womens Health
New Therapeutic Targets for Cancer: The Interplay Between Immune and Metabolic Checkpoints and Gut Microbiota
Clinical and Translational Medicine
Medicine
Molecular Medicine
NK Cell-Based Glioblastoma Immunotherapy
Cancers
Cancer Research
Oncology
Rho GTPases as Therapeutic Targets in Cancer (Review)
International Journal of Oncology
Cancer Research
Oncology
Post-Translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention
Frontiers in Immunology
Allergy
Immunology
Oncogenes as Therapeutic Targets in Cancer: A Review
IOSR Journal of Dental and Medical Sciences